PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 29322752
OWN - NLM
STAT- MEDLINE
DCOM- 20180112
LR  - 20180112
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 378
IP  - 2
DP  - 2018 Jan 11
TI  - Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.
PG  - 194-5
LID - 10.1056/NEJMc1714810 [doi]
FAU - Lewis, Joshua R
AU  - Lewis JR
FAU - Schousboe, John T
AU  - Schousboe JT
FAU - Prince, Richard L
AU  - Prince RL
LA  - eng
PT  - Letter
PT  - Comment
DEP - 20180111
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Antibodies, Monoclonal)
RN  - 3VHF2ZD92J (AMG 785)
RN  - X1J18R4W8P (Alendronate)
SB  - AIM
SB  - IM
CON - N Engl J Med. 2017 Oct 12;377(15):1417-1427. PMID: 28892457
CIN - N Engl J Med. 2018 Jan 11;378(2):194-196. PMID: 29320649
MH  - *Alendronate
MH  - Antibodies, Monoclonal
MH  - Female
MH  - Fractures, Bone
MH  - Humans
MH  - *Osteoporosis
EDAT- 2018/01/13 06:00
MHDA- 2018/01/13 06:01
CRDT- 2018/01/12 06:00
PHST- 2018/01/12 06:00 [entrez]
PHST- 2018/01/13 06:00 [pubmed]
PHST- 2018/01/13 06:01 [medline]
PST - epublish
SO  - N Engl J Med. 2018 Jan 11;378(2):194-5.